Copeland Capital Management, LLC Abb Vie Inc. Transaction History

Copeland Capital Management, LLC

$5.61 Billion
Q3 2024

A detailed history of Copeland Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Copeland Capital Management, LLC holds 1,323 shares of ABBV stock, worth $226,947. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,323

Previous 1,323 -0.0%

Holding current value

$226,947

Previous $226,000 15.49%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $18,539 - $21,123	-116 Reduced 8.06%	1,323 $240,000
Q4 2023 Jan 19, 2024	SELL	$137.6 - $154.97 $28,345 - $31,923	-206 Reduced 12.52%	1,439 $223,000
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $1,335 - $1,546	-10 Reduced 0.6%	1,645 $245,000
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $1,987 - $2,473	-15 Reduced 0.9%	1,655 $222,000
Q1 2023 Apr 14, 2023	SELL	$144.61 - $166.54 $7,230 - $8,327	-50 Reduced 2.91%	1,670 $266,000
Q3 2022 Oct 12, 2022	SELL	$134.21 - $153.93 $19,460 - $22,319	-145 Reduced 7.77%	1,720 $231,000
Q2 2022 Jul 15, 2022	SELL	$137.62 - $174.96 $1,376 - $1,749	-10 Reduced 0.53%	1,865 $286,000
Q1 2022 Apr 18, 2022	SELL	$131.98 - $163.75 $10,294 - $12,772	-78 Reduced 3.99%	1,875 $304,000
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $2,660 - $3,019	-25 Reduced 1.26%	1,953 $211,000
Q3 2020 Jan 18, 2022	BUY	$85.91 - $100.83 $169,929 - $199,441	1,978 New	1,978 $173,000
Q3 2020 Oct 22, 2020	SELL	$85.91 - $100.83 $169,929 - $199,441	-1,978 Closed	0 $0
Q2 2020 Jan 18, 2022	BUY	$73.37 - $98.18 $145,125 - $194,200	1,978 New	1,978 $194,000
Q2 2020 Jul 30, 2020	SELL	$73.37 - $98.18 $145,125 - $194,200	-1,978 Closed	0 $0
Q1 2020 Jan 18, 2022	BUY	$64.5 - $97.79 $127,581 - $193,428	1,978 New	1,978 $151,000
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $132,354 - $200,665	-2,052 Closed	0 $0
Q4 2019 Jan 18, 2022	BUY	$72.13 - $90.25 $148,010 - $185,193	2,052 New	2,052 $182,000
Q4 2019 Feb 03, 2020	SELL	$72.13 - $90.25 $148,010 - $185,193	-2,052 Closed	0 $0
Q3 2019 Jan 18, 2022	BUY	$62.98 - $75.72 $129,234 - $155,377	2,052 New	2,052 $155,000
Q3 2019 Nov 06, 2019	SELL	$62.98 - $75.72 $150,081 - $180,440	-2,383 Closed	0 $0
Q2 2019 Jan 18, 2022	BUY	$65.7 - $83.98 $156,563 - $200,124	2,383 New	2,383 $173,000
Q2 2019 Jul 19, 2019	SELL	$65.7 - $83.98 $179,558 - $229,517	-2,733 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$77.14 - $90.79 $77,140 - $90,790	-1,000 Reduced 26.79%	2,733 $220,000
Q4 2018 Jan 28, 2019	SELL	$77.85 - $96.01 $10,899 - $13,441	-140 Reduced 3.61%	3,733 $344,000
Q3 2018 Nov 01, 2018	SELL	$88.91 - $98.84 $43,121 - $47,937	-485 Reduced 11.13%	3,873 $366,000
Q2 2018 Jul 17, 2018	BUY	$89.78 - $106.23 $14,364 - $16,996	160 Added 3.81%	4,358 $404,000
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $46,097 - $61,728	-501 Reduced 10.66%	4,198 $397,000
Q4 2017 Jan 30, 2018	BUY	$89.56 - $98.21 $1,432 - $1,571	16 Added 0.34%	4,699 $454,000
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $327,107 - $417,817	4,683	4,683 $416,000

Others Institutions Holding ABBV

# of Institutions

3,863

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copeland Capital Management, LLC with notifications on news.

Account

Copeland Capital Management, LLC Abb Vie Inc. Transaction History